Danish pharma huge Novo Nordisk teased promising early-phase trial results of its experimental weight loss capsule amycretin, sending the corporation’s stock surging.“I used to constantly crave food generally. I was normally hungry before beginning the Body System.”We’re pushing every day to obtain medication to our sufferers more rapidly.